Derivative exercise or conversion — not an open-market buy.
Traded Feb 3, 2026 · Filed Feb 6, 2026
A board member of Baker Hughes sold $1.03M of Baker Hughes shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$1,032,538
Shares × reported transaction price
8 days after results of Jan 26, 2026, 79 days before results of Apr 23, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $58.00 on Feb 3, 2026, at its 52-week high, after a 30% rise over the previous 30 trading days
52-week range $35.00 (Apr 8, 2025) to $58.00 (Feb 3, 2026), 100% of the way up, from 251 adjusted closes. 30 trading days earlier: $44.47 on Dec 18, 2025. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +0.5% | -1.6% | +2.1% |
| 30 days | -1.0% | -2.5% | +1.6% |
| 90 days | +8.5% | +6.5% | +1.9% |
| 180 days | +7.6% | +11.4% | -3.8% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
CEO sold ~$16.7M of Baker Hughes
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.